These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 6210393

  • 1. Systemic compliance, renal hemodynamics, and sodium excretion in hypertension.
    London GM, Levenson JA, London AM, Simon AC, Safar ME.
    Kidney Int; 1984 Sep; 26(3):342-50. PubMed ID: 6210393
    [Abstract] [Full Text] [Related]

  • 2. Plasma prostaglandins PGE2 and PGF2 alpha, total effective vascular compliance and renal plasma flow in essential hypertension.
    London GM, Hornych A, Safar ME, Levenson JA, Simon AC.
    Nephron; 1982 Sep; 32(2):118-24. PubMed ID: 6960267
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 4. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB.
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [Abstract] [Full Text] [Related]

  • 5. Renal sodium excretion and the peritubular capillary physical factors in essential hypertension.
    Willassen Y, Ofstad J.
    Hypertension; 1980 Mar; 2(6):771-9. PubMed ID: 7461793
    [Abstract] [Full Text] [Related]

  • 6. Intrarenal pressure and sodium excretion in hypertension of chronic glomerulonephritis in humans.
    Willassen Y, Ofstad J.
    Hypertension; 1983 Mar; 5(3):375-84. PubMed ID: 6840824
    [Abstract] [Full Text] [Related]

  • 7. Renal filtration fraction, effective vascular compliance, and partition of fluid volumes in sustained essential hypertension.
    London GM, Safar ME, Levenson JA, Simon AC, Temmar MA.
    Kidney Int; 1981 Jul; 20(1):97-103. PubMed ID: 7300119
    [Abstract] [Full Text] [Related]

  • 8. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of atrial natriuretic peptide during dopamine infusion.
    Hirata Y, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T.
    Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625
    [Abstract] [Full Text] [Related]

  • 10. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H, Jungersten LU, Wikstrand J, Widgren BR.
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [Abstract] [Full Text] [Related]

  • 11. Extracellular fluid volume and renal indices in essential hypertension.
    Simon AC, Safar ME, Levenson JA, Aboras NE, Alexandre JM, Pauleau NF.
    Clin Exp Hypertens (1978); 1979 Nov; 1(5):557-76. PubMed ID: 533674
    [Abstract] [Full Text] [Related]

  • 12. Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery.
    London GM, Safar ME.
    Am J Hypertens; 1989 Apr; 2(4):244-52. PubMed ID: 2706091
    [Abstract] [Full Text] [Related]

  • 13. Intrarenal hemodynamics in patients with essential hypertension.
    Kimura G, Imanishi M, Sanai T, Kawano Y, Kojima S, Yoshida K, Abe H, Ashida T, Yoshimi H, Kawamura M.
    Circ Res; 1991 Aug; 69(2):421-8. PubMed ID: 1860182
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.
    Predel HG, Schulte-Vels O, Glänzer K, Meyer-Lehnert H, Kramer HJ.
    Am J Hypertens; 1991 Nov; 4(11):871-9. PubMed ID: 1665067
    [Abstract] [Full Text] [Related]

  • 15. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
    Widgren BR.
    Scand J Urol Nephrol Suppl; 1991 Nov; 134():1-75. PubMed ID: 1887213
    [Abstract] [Full Text] [Related]

  • 16. The effect of dietary sodium loading on the kinetics of sodium excretion and blood pressure regulation in essential hypertensive men.
    Manitius J, Kliz J, Krupa-Wojciechowska B.
    Cor Vasa; 1985 Nov; 27(1):29-35. PubMed ID: 3888529
    [Abstract] [Full Text] [Related]

  • 17. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K, Kimura G, Imanishi M, Sanai T, Kawano Y, Kojima S, Yoshida K, Abe H, Ashida T, Yoshimi H.
    Blood Press Suppl; 1992 Nov; 3():114-8. PubMed ID: 1343278
    [Abstract] [Full Text] [Related]

  • 18. Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
    Ruilope LM, Miranda B, Garcia-Robles R, Bigorra J, Oliet A, Alcazar JM, Sancho Rof J, Rodicio JL.
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):90-3. PubMed ID: 2468941
    [Abstract] [Full Text] [Related]

  • 19. Role of renal hemodynamics in the exaggerated natriuresis of essential hypertension.
    Coruzzi P, Musiari L, Biggi A, Ravanetti C, Vallisa D, Montanari A, Novarini A.
    Kidney Int; 1988 Apr; 33(4):875-80. PubMed ID: 3386140
    [Abstract] [Full Text] [Related]

  • 20. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G.
    Hypertension; 1983 Apr; 5(3):368-74. PubMed ID: 6341220
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.